Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
DAWN
DAWN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest DAWN ETF News Today | Earnings, Events & Price Alerts
DAWN News
Day One Biopharmaceuticals Reports Q4 and Full-Year 2025 Financial Results
6d ago
NASDAQ.COM
Day One Biopharmaceuticals Reports Strong Q4 2025 Earnings and Growth Outlook
Feb 25 2026
seekingalpha
Day One Biopharmaceuticals Reports Q4 2025 Earnings Highlights
Feb 24 2026
seekingalpha
Day One Biopharmaceuticals Reports Strong 2025 Financial Results and Growth Outlook
Feb 24 2026
Yahoo Finance
Day One Biopharmaceuticals Set to Release Q4 Earnings on February 24
Feb 23 2026
seekingalpha
AIGH Capital Fully Exits Lumen Technologies Stake
Feb 03 2026
Fool
Kevin Mahn Advises Investors to Focus on Long-Term Growth Amid Market Volatility
Jan 21 2026
Benzinga
Day One Biopharmaceuticals Reports $155.4M Revenue for 2025, Projects 53% Growth in 2026
Jan 14 2026
seekingalpha
U.S. Stocks Mixed; Day One Biopharmaceuticals Shares Surge 20%
Jan 12 2026
Benzinga
Planet Labs PBC Secures Nine-Figure Deal with Swedish Armed Forces, Shares Surge 7%
Jan 12 2026
Benzinga
Day One Biopharmaceuticals Reports $155.4M OJEMDA Revenue for 2025
Jan 12 2026
NASDAQ.COM
Day One Biopharmaceuticals Reports $155.4M in 2025 Net Revenue, Up 172%
Jan 11 2026
Globenewswire
Day One Biopharmaceuticals Reports $155.4M in 2025 Net Revenue, Up 172%
Jan 11 2026
Yahoo Finance
Day One Acquires Mersana for $25 per Share, Expanding Oncology Pipeline
Jan 06 2026
Globenewswire
After-Hours Gains on Friday: Biotech and Genomics Stocks Demonstrate Resilience
Dec 22 2025
NASDAQ.COM
Significant Options Trading on Friday: DAWN, XPO, UUUU
Dec 19 2025
NASDAQ.COM
Show More News
